1887

Abstract

Summary

Sera from 489 trainee nurses were examined, by the ELISA technique, for the presence of varicella-zoster virus specific antibody; antibody was found in 446 (91.2%). In more detailed investigations of specific immunity in 33 healthy adults with a past history of chickenpox, 32 (97%) showed a positive lymphocyte transformation test, but only 11 out of 23 examined (48%) demonstrated mononuclear cell production of specific antibody ; serum antibody was found in 30 (91%) by the ELISA and in 25 out of 26 examined (96%) by the FAMA technique. A high degree of correlation was found between both a positive lymphocyte transformation and the presence of serum antibody and a past history of chickenpox.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-20-1-105
1985-08-01
2024-04-23
Loading full text...

Full text loading...

/deliver/fulltext/jmm/20/1/medmicro-20-1-105.html?itemId=/content/journal/jmm/10.1099/00222615-20-1-105&mimeType=html&fmt=ahah

References

  1. Arbeter A. M. et al. 1984; Varicella vaccine trials in healthy children: A summary of comparative and follow-up studies. American Journal of Diseases of Children 138:434–438
    [Google Scholar]
  2. Arbeter A. M., Starr S. E., Weibel R. E., Plotkin S. A. 1982; Live attenuated varicella vaccine: Immunization of healthy children with the OKA strain. Journal of Pediatrics 100:886–893
    [Google Scholar]
  3. Arvin A. M., Pollard R. B., Rasmussen L. E., Merigan T. C. 1978; Selective impairment of lymphocyte reactivity to varicella-zoster virus antigen among untreated patients with lymphoma. Journal of Infectious Diseases 137:531–540
    [Google Scholar]
  4. Asano Y., Albrecht P., Vujcic L. K., Quinnan G. V., Kawakami K., Takahashi M. 1983; Five year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays. Pediatrics 72:291–294
    [Google Scholar]
  5. Brunell P. A. 1977; Protection against varicella. Pediatrics 59:1–2
    [Google Scholar]
  6. Faizallah R., Green H. T., Krasner N., Walker R. J. 1982; Outbreak of chickenpox from a patient with immuosuppressed herpes zoster in hospital. British Medical Journal 2:1022–1023
    [Google Scholar]
  7. Feldman S., Hughes W. T., Daniel C. B. 1975; Varicella in children with cancer: seventy seven cases. Pediatrics 56:388–397
    [Google Scholar]
  8. Feldman S., Hughes W. T., Kim H. Y. 1973; Herpes zoster in children with cancer. American Journal of Diseases of Children 126:178–184
    [Google Scholar]
  9. Gershon A. A., Steinberg S. P., Borkowsky W., Lennette D., Lennette E. 1982; IgM to varicella-zoster virus: demonstration in patients with and without clinical zoster. Pediatric Infectious Diseases 1:164–167
    [Google Scholar]
  10. Gustafson T. L., Shebab Z., Brunell P. A. 1984; Outbreak of varicella in a newborn intensive care nursery. American Journal of Diseases of Children 138:548–550
    [Google Scholar]
  11. Neff B. et al. 1981; Clinical and laboratory studies of KMcC strain live attenuated varicella virus. Proceedings of the Society for Experimental Biology and Medicine 166:339–347
    [Google Scholar]
  12. Patel P. A., Yoonessi S., O’Malley J., Freeman A., Gershon A., Ogra P. L. 1979; Cell-mediated immunity to varicella-zoster virus infection in subjects with lymphoma or leukemia. Journal of Pediatrics 94:223–230
    [Google Scholar]
  13. Preblud S. R. 1981; Age specific risks of varicella complications. Pediatrics 68:14–17
    [Google Scholar]
  14. Ross A. H. 1962; Modification of chickenpox in family contacts by administration of gamma globulin. New England Journal of Medicine 267:369–376
    [Google Scholar]
  15. Shanley J., Myers M., Edmond B., Steele R. 1982; Enzyme-linked immuno-sorbent assay for detection of antibody to varicella-zoster virus. Journal of Clinical Microbiology 15:208–211
    [Google Scholar]
  16. Souhami R. L., Babbage J., Callard RE. 1981; Specific in vitro antibody response to varicella zoster. Clinical and Experimental Immunology 46:98–105
    [Google Scholar]
  17. Takahashi M., Otsuka T., Okuno Y., Asano Y., Yazaki T., Isomura S. 1984; Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2:1288–1290
    [Google Scholar]
  18. Tomlinson A. H., MacCallum F. O. 1970; The incidence of complement-fixing antibody to varicella-zoster virus in hospital patients and blood donors. Journal of Hygiene 68:411–416
    [Google Scholar]
  19. Ward F., Campbell-Benzie A., Heath R. B. 1982; Fluorescent antibody to membrane antigen (FAMA) procedure for determining susceptibility to varicella: an evaluation. Medical and Laboratory Science 39:33–38
    [Google Scholar]
  20. Weibel R. E. et al. 1984; Live attenuated varicella virus vaccine. Efficacy trial in healthy children. New England Journal of Medicine 310:1409–1415
    [Google Scholar]
  21. Weller T. H. 1983; Varicella and herpes zoster. Changing concepts of the natural history, control and importance of a not-so-benign virus. New England Journal of Medicine 309:1362–1368
    [Google Scholar]
  22. Williams V., Gershon A., Brunell P. A. 1974; Serologic response to varicella-zoster membrane antigens measured by indirect immunuofluorescence. Journal of Infectious Diseases 130:669–672
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-20-1-105
Loading
/content/journal/jmm/10.1099/00222615-20-1-105
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error